Ritaskrá Háskóla Íslands - 01.05.2007, Blaðsíða 83

83
Nýjungar í barnalækningum – Unglæknadagurinn, 18. febrúar
2006.
Eyrnabólgur og ónæmiskerfið. Málþing um miðeyrnabólgur á
vegum háls-, nef- og eyrnalækninga læknadeildar Háskóla
Íslands. Des 2006.
Erfðafræði
Jórunn E. Eyfjörð prófessor
Greinar í ritrýndum fræðiritum
Population-Based Study of Changing Breast Cancer Risk in
Icelandic BRCA2 Mutation Carriers, 1920–2000. J Natl
Cancer Inst; 98: 116-122 (2006). Laufey Tryggvadottir, Helgi
Sigvaldason, Gudridur H. Olafsdottir, Jon G. Jonasson,
Thorvaldur Jonsson, Hrafn Tulinius, Jorunn E. Eyfjörd.
Clinical value of somatic TP53 gene mutations in 1794 breast
cancer patients. Clin Ca Res, 12, 1157-1167 (2006). Magali
Olivier, Anita Langerød, Patrizia Carrieri, Jonas Bergh,
Sigrid Klaar, Jorunn Eyfjord, Charles Theillet, Carmen
Rodriguez, Rosette Lidereau, Ivan Bièche, Jennifer Varley,
Yves Bignon, Nancy Uhrhammer, Robert Winqvist, Arja
Jukkola-Vuorinen, Dieter Niederacher, Shunsuke Kato,
Chikashi Ishioka, Pierre Hainaut, Anne-Lise Børresen-
Dale.
Epigenetic silencing and deletion of the BRCA1 gene in sporadic
breast cancer. Breast Cancer Res. Jul 17;8(4):R38 (2006).
Valgerdur Birgisdottir, Olafur A Stefansson, Sigridur K
Bodvarsdottir, Holmfridur Hilmarsdottir, Jon G Jonasson,
Jorunn E Eyfjord. Greinin var sérstaklega “higlighted” á
vefsíðu Breast Cancer Res fyrir júlímánuð 2006.
Aurora-A amplification associated with BRCA2 mutation in
breast tumours. Cancer Lett. Jul 21; [Epub ahead of print]
(2006). Sigridur K. Bodvarsdottir, Margret Steinarsdottir,
Valgerdur Birgisdottir, Holmfridur Hilmarsdottir, Jon G.
Jonasson, Jorunn E. Eyfjord.
Positive association between plasma antioxidant capacity and
n-3 PUFA in red blood cells from Icelandic women. Lipids
41 (2): 119-125 Feb (2006). Thorlaksdottir AY, Skuladottir GV,
Petursdottir AL, Tryggvadottir L, Ogmundsdottir HM,
Eyfjord JE, Jonsson JJ, Hardardottir I.
Breast cancer risk associated with Aurora-A 91T->A
polymorphism in relation to BRCA2 mutation. Cancer Lett
2006 Nov 16; [Epub ahead of print] (2006). Linda
Vidarsdottir Sigridur K. Bodvarsdottir, Holmfridur
Hilmarsdottir, Laufey Tryggvadottir, Jorunn E. Eyfjord.
Fyrirlestrar
Gestafyrirlestur: BRCA genes in an Island Population.
Innovations in Research: Implications for Health Services
and Policy. Jórunn Erla Eyfjörð. St. John´s, Newfoundland.
Oct 19, 2006. Plenary. Þátttaka í pallborðsumræðum sama
dag og fundum með rannsóknahópum 20. október.
NLCAHR http://www.nlcahr.mun.ca/.
Prostate cancer survival in BRCA2 mutation carriers. Jórunn
Erla Eyfjörd. IMPACT steering committee meeting, London,
17. mars 2006
IMPACT Identification of Men with genetic predisposition to
Prostate Cancer: Targeted Screening in BRCA1/2 mutation
carriers and non-carriers. Survival in BRCA2 prostate
cancer cases. Ráðstefna í Szczecin, Póllandi, 28.-30.
nóvember 2006. Jórunn E. Eyfjörd.
Veggspjald
Formation of Rad51foci in breast epithelial cell lines carrying a
BRCA2 mutation. EACR meeting, Búdapest, Ungverjalandi,
1.-4. júlí 2006. Jenny B. Thorsteinsdottir, Gardar Myrdal,
Jorunn E. Eyfjörd & Helga M. Ögmundsdottir.
Frumulíffræði
Helga M. Ögmundsdóttir prófessor
Greinar í ritrýndum fræðiritum
Establishment of three human breast epithelial cell lines
derived from carriers of the 999del5 BRCA2 Icelandic
founder mutation. In Vitro Cell Dev Biol Anim. 2005. 41:337-
342. Fridriksdottir AJR, Gudjonsson Th, Halldorsson Th,
Björnsson J, Steinarsdottir M, Johannsson OTh,
Ögmundsdottir HM.
Effect of hypoxia and TP53 mutation status on culture and
cytogenetics of normal and malignant mammary
epithelium. Cancer Genet Cytogenet 2006. 165:144-
150.Vidarsson H, Steinarsdóttir M, Jónasson JG ,
Júlíusdóttir H, Hauksdóttir H , Hilmarsdóttir H,
Halldórsdóttir K, Ögmundsdóttir HM.
Evidence for extrathymic T-cell maturation after thymectomy in
infancy. Clin Exp Immunol 2006. 145: 407-412. Torfadottir H,
Freysdottir J, Skaftadottir I, Haraldsson A, Sigfusson G,
Ögmundsdottir HM.
Positive association between plasma antioxidant capacity and
n-3 PUFA in red blood cells from Icelandic women. Lipids
2006. 41: 119-125. Thorlaksdottir AY, Skuladottir GV,
Petursdottir AL, Tryggvadottir L, Ogmundsdottir HM,
Eyfjord JE, Jonsson JJ, Hardardottir I.
Human breast endothelial cells retain their phenotypic traits of
origin after prolonged culture in vitro. In Vitro Cell Dev Biol
Anim 2006. 42:332-340. Sigurdsson V, Fridriksdottir AJ,
Kjartansson J, Jonasson JG, Steinarsdottir M,
Ogmundsdottir HM, Gudjonsson T.
Fyrirlestur
Therapeutic vaccines against cancer. Helga M. Ögmundsdóttir.
Nordic Vaccine Meeting, Reykjavík. Pre-Conference
Symposium, 24. ágúst 2006.
Veggspjöld
Monoclonal gammopathy: Natural history studied with a
retrospective approach. 11th Congress of the European
Hematology Association, Amsterdam, Hollandi, 15.-18. júní
2006. Hlín Steingrímsdóttir, Vilhelmína Haraldsdóttir,
Vilmundur Guðnason, Ísleifur Ólafsson, Helga M.
Ögmundsdóttir.
Formation of Rad51 foci in breast epithelial cell lines carrying a
BRCA2 mutation. 19th Meeting of the European Association
for Cancer Research, Búdapest, Ungverjalandi, 1.-4. júlí
2006. Jenný Björk Þorsteinsdóttir, Garðar Mýrdal, Jórunn
Erla Eyfjörð, Helga M. Ögmundsdóttir.
Usnic acid: anti-proliferative, apoptotic and morphological
effects on human malignant cell lines. Guðleif Harðardóttir,
Helga M. Ögmundsdóttir, Kristín Ingólfsdóttir. 54th Annual
Congress on Medicinal Plant Research, Helsinki, Finnlandi,
29. ágúst-2. september,2006.
Fræðsluefni
Svar á vísindavefnum: Er túmorsjúkdómurinn í Mýrinni eftir
Arnald Indriðason til í alvörunni? Birt 15.5.2006.
Þórarinn Guðjónsson sérfræðingur
Greinar í ritrýndum fræðiritum
Gudjonsson, T., Adriance, M.C., Sternlicht, M.D., Petersen, O.W.,
and Bissell, M.J. (2006). Myoepithelial cells: Their origin
and function in breast morphogenesis and neoplasia. J
Mammary Gland Biol Neoplasia. 10(3): 261-72.
Asgrimsson, V., Gudjonsson, T., Gudmundsson, G.H., and
Baldursson, O. (2005).The macrolide antibiotic